EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹707 Cr | ₹528 Cr | ₹562 Cr | ₹703 Cr | ₹419 Cr |
What is the latest Profit After Tax of EMCURE PHARMACEUTICALS ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹707 Cr |
| Mar2024 | ₹528 Cr |
| Mar2023 | ₹562 Cr |
| Mar2022 | ₹703 Cr |
| Mar2021 | ₹419 Cr |
How is Profit After Tax of EMCURE PHARMACEUTICALS Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹707 Cr | 34.10 | |
| Mar2024 | ₹528 Cr | -6.10 | |
| Mar2023 | ₹562 Cr | -20.03 | |
| Mar2022 | ₹703 Cr | 67.84 | |
| Mar2021 | ₹419 Cr | - | |
Compare Profit After Tax of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹29,600.4 Cr | 7.5% | 1% | 61.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,855.0 Cr | 2.4% | 7.1% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,550.0 Cr | -0.2% | 3.8% | 15.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,906.0 Cr | 1.8% | 10.9% | 48.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,632.0 Cr | 1% | 4% | 16.6% | Stock Analytics | |
| CIPLA | ₹107,427.0 Cr | 0.3% | -0.9% | -6% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 7.5% |
1% |
61.6% |
| SENSEX | -2.9% |
-8% |
5.3% |
You may also like the below Video Courses